Robotic Treatment For Spinal Cord Injuries Available In US

Brooks Rehabilitation, in partnership with Japanese medical company CYBERDYNE, introduces what it’s calling the first advanced robotic treatment device that has been shown to improve a patient's ability to walk. Individuals with spinal cord injuries can now access FDA-cleared HAL, which is short for Hybrid Assistive Limb, at the Brooks Cybernic Treatment Center in Jacksonville, FL. The Treatment Center is currently the only facility in the US offering the treatment.

 

HAL fits to the patient's lower limbs and trunk, and operates using internal signals from the body. This powered lower extremity exoskeleton is unique from other exoskeleton treatments because the device's movements are neurologically-controlled by the patient's volition, and use of its secondary Biofeedback Device features allows the patient to see and adjust the signals they are producing.

Fierce AI Week

Register today for Fierce AI Week - a free virtual event | August 10-12

Advances in AI and Machine Learning are adding an unprecedented level of intelligence to everything through capabilities such as speech processing and image & facial recognition. An essential event for design engineers and AI professionals, Engineering AI sessions during Fierce AI Week explore some of the most innovative real-world applications today, the technological advances that are accelerating adoption of AI and Machine Learning, and what the future holds for this game-changing technology.

 

How It Works:

  • Sensors attach to the patient's lower extremities.
  • When the patient intends to move, muscles receive nerve signals from the brain, and faint bio-electrical signals are detected on the skin's surface.
  • HAL uses sensors to detect these signals and assists with desired movements, while also enhancing strength and stability.
  • Active use of neural pathways for voluntary movement with physical feedback to the brain leads to improved ability for the patient to walk on their own. 

The innovation for Cyberdyne, Inc. and HAL is that of Dr. Yoshiyuki Sankai, President and CEO of Cyberdyne, Inc. and Professor at the University of Tsukuba, Japan. Patients who participate in HAL treatments at the Brooks Cybernic Treatment Center can also choose to share their treatment data for clinical research trials that further evaluate the benefits of HAL interventions and future improvement opportunities.

 

For more information, checkout HAL at Brooks Rehabilitation. For even more details, visit HAL at Cyberdyne, Inc.

Read more on

Suggested Articles

HP leads the pack, but Apple sees 36% surge in notebooks, desktops compared to a year ago

New York City residents moving upstate will give hundreds of towns extra tax revenue to invest in new streetlights with IoT sensors, NYPA foresees

With about one-fifth the revenues of Intel, Nvidia’s market capitalization exceeds Intel’s as Nvidia stock hits record high